Vidar S.
- Country
- Norway
- Department
- Hematology
Research Overview
- Randomized Controlled Trial Comparing Avatrombopag and Rituximab in Adult Patients with Immune Thrombocytopenia Unresponsive to Corticosteroids
- Evaluation of Lenalidomide, Bortezomib, and Dexamethasone in Early Versus Standard Treatment of Multiple Myeloma Relapse from MRD Negativity
- Phase 3 Study on Efficacy and Safety of Human Normal Immunoglobulin for Infection Prophylaxis in Multiple Myeloma Patients on Teclistamab Therapy
Data & Insights
Has run more than one trial at 9 of 58 partner sites.
Specializations
Thoracic oncology
Clinical research in small-cell lung cancer and non-small cell lung cancer, with a focus on immunotherapy, chemoradiotherapy, and combined treatment strategies for locally advanced and metastatic disease.
- Limited disease small-cell lung cancer
- Extensive stage small-cell lung cancer
- Advanced or metastatic non-small cell lung cancer
- Thoracic radiotherapy
- PD-1/PD-L1 inhibition
Interest includes atezolizumab-based treatment, durvalumab-containing regimens, and precision cancer medicine for difficult-to-treat thoracic malignancies.
Neuroimmunology and migraine
Work in multiple sclerosis and chronic migraine spans immune-mediated neurological disease and symptom control, with attention to disease-modifying therapy and headache prevention.
- Relapsing-remitting multiple sclerosis
- Ocrelizumab
- Rituximab
- CGRP monoclonal antibodies
- Onabotulinumtoxin A
Clinical activity also includes comparative evaluation of biologic therapies for neurological and headache disorders.
Inflammatory bowel disease and immune-mediated disorders
Research involvement covers Crohn's disease and immune thrombocytopenia, with emphasis on maintenance treatment, relapse prevention, and immune-targeted therapy selection.
- Crohn's disease
- Immune thrombocytopenia (ITP)
- Risankizumab
- Avatrombopag
- Rituximab
Additional interest extends to long-term safety, tolerability, and sustained disease control in chronic immune-mediated conditions.
Multiple myeloma and infection prevention
Clinical trial activity includes multiple myeloma and supportive care for treatment-related immune suppression, particularly infection prevention in patients receiving advanced immune-based therapy.
- Multiple myeloma
- Minimal residual disease
- BCMA-directed bispecific therapy
- Primary infection prophylaxis
- Immune globulin infusion
Research also includes early treatment strategies guided by MRD negativity and relapse detection.
Precision oncology and rare cancers
Investigator involvement extends to genomically guided cancer treatment for patients with advanced, rare, or hard-to-treat malignancies, using targeted agents matched to molecular features.
- Advanced malignancy
- Rare cancers
- Targeted anti-cancer drugs
- Genomic biomarkers
- Protein expression variants
There is also interest in adrenal insufficiency and treatment-related quality of life in chronic endocrine care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.